Literature DB >> 21715465

Mild hypercholesterolemia, normal plasma triglycerides, and normal glucose levels across dementia staging in Alzheimer's disease: a clinical setting-based retrospective study.

Said Ramdane1, Doria Daoudi-Gueddah.   

Abstract

We examined retrospectively the concurrent relationships between fasting plasma total cholesterol, triglycerides, and glucose levels, and Alzheimer's disease (AD), in a clinical setting-based study. Total cholesterol level was higher in patients with AD compared to elderly controls; triglycerides or glucose levels did not significantly differ between the 2 groups. Respective plotted trajectories of change in cholesterol level across age were fairly parallel. No significant difference in total cholesterol levels was recorded between patients with AD classified by the Clinical Dementia Rating (CDR) score subgroups. These results suggest that patients with AD have relative mild total hypercholesterolemia, normal triglyceridemia, and normal fasting plasma glucose level. Mild total hypercholesterolemia seems to be permanent across age, and across dementia severity staging, and fairly parallels the trajectory of age-related change in total cholesterolemia of healthy controls. We speculate that these biochemical parameters pattern may be present long before-a decade at least-the symptomatic onset of the disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21715465     DOI: 10.1177/1533317511414552

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  3 in total

1.  Diphenyl diselenide prevents cortico-cerebral mitochondrial dysfunction and oxidative stress induced by hypercholesterolemia in LDL receptor knockout mice.

Authors:  Jade de Oliveira; Eduardo Luiz Gasnhar Moreira; Gianni Mancini; Mariana Appel Hort; Alexandra Latini; Rosa Maria Ribeiro-do-Valle; Marcelo Farina; João Batista Teixeira da Rocha; Andreza Fabro de Bem
Journal:  Neurochem Res       Date:  2013-07-24       Impact factor: 3.996

Review 2.  Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment.

Authors:  Sasanka Chakrabarti; Vineet Kumar Khemka; Anindita Banerjee; Gargi Chatterjee; Anirban Ganguly; Atanu Biswas
Journal:  Aging Dis       Date:  2015-08-01       Impact factor: 6.745

3.  Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance.

Authors:  Steve Pedrini; Eugene Hone; Veer B Gupta; Ian James; Elham Teimouri; Ashley I Bush; Christopher C Rowe; Victor L Villemagne; David Ames; Colin L Masters; Stephanie Rainey-Smith; Giuseppe Verdile; Hamid R Sohrabi; Manfred R Raida; Markus R Wenk; Kevin Taddei; Pratishtha Chatterjee; Ian Martins; Simon M Laws; Ralph N Martins
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.